Gen-Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Gen-Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Sell	207 -51	-20%	-$28.6K	0.03%	319
2026 Q1	$145K	Sell	258 -97	-27%	-$62.2K	0.05%	283
2025 Q4	$240K	Sell	355 -106	-23%	-$72.2K	0.08%	241
2025 Q3	$295K	Sell	461 -97	-17%	-$58.9K	0.1%	205
2025 Q2	$299K	Buy	558 +29	+5%	+$13.9K	0.12%	170
2025 Q1	$222K	Sell	529 -9	-2%	-$3.91K	0.09%	196
2024 Q4	$222K	Buy	538 +21	+4%	+$9.21K	0.1%	201
2024 Q3	$233K	Buy	517 +117	+29%	+$56.8K	0.1%	201
2024 Q2	$195K	Buy	400 +91	+29%	+$45.7K	0.09%	212
2024 Q1	$167K	Buy	+309	New	+$169K	0.08%	238

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Gen-Wealth Partners's IDXX Position: Q2 2026 in Review

Gen-Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 20% in Q2 2026, selling an estimated $28.6K and leaving 207 shares worth $109K. The position accounts for 0.03% of the portfolio, ranked #319.

Gen-Wealth Partners first reported a position in IDXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $299K in Q2 2025. 773 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Gen-Wealth Partners held 207 shares of Idexx Laboratories worth $109K as of Q2 2026.
Gen-Wealth Partners sold 51 Idexx Laboratories shares in Q2 2026, an estimated $28.6K.
Idexx Laboratories made up 0.03% of Gen-Wealth Partners's portfolio in Q2 2026, its #319 holding.
Gen-Wealth Partners first reported a position in Idexx Laboratories in Q1 2024 and has held it in 10 quarters since.
Gen-Wealth Partners's Idexx Laboratories position peaked at $299K in Q2 2025.
773 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.